Clinical trial
Effect of Ezetimibe on Platelet Aggregation and LDL Tendency to Peroxidation
NCT00466401 · Ziv Hospital, Other · Completed
Key facts
| NCT number | NCT00466401 |
|---|---|
| Title | Effect of Ezetimibe on Platelet Aggregation and LDL Tendency to Peroxidation |
| Official title | Phase 4 Study on Effect of Ezetimibe on Platelet Aggregation and LDL Tendency to Peroxidation In Hypercholesterolemic Patients on Simvastatin |
| Lead sponsor | Ziv Hospital, Other |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | Simvastatin, Ezetimibe |
| Enrollment | 20 |
| Start date | Feb 1, 2005 |
| Completion | Aug 1, 2007 |
| First posted | Apr 27, 2007 |
| Last update posted | Feb 20, 2013 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: